1. Crucial roles of exosomes secreted from ganglioside GD3/GD2-positive glioma cells in enhancement of the malignant phenotypes and signals of GD3/GD2-negative glioma cells.
- Author
-
Hasnat MA, Ohmi Y, Yesmin F, Kambe M, Kawamoto Y, Bhuiyan RH, Mizutani M, Hashimoto N, Tsuchida A, Ohkawa Y, Kaneko K, Tajima O, Furukawa K, and Furukawa K
- Subjects
- Humans, Cell Line, Tumor, Phosphorylation, Signal Transduction, Brain Neoplasms metabolism, Brain Neoplasms pathology, Paxillin metabolism, Gangliosides metabolism, Exosomes metabolism, Glioma metabolism, Glioma pathology, Phenotype
- Abstract
Neuroectoderm-derived tumors characteristically express gangliosides such as GD3 and GD2. Many studies have reported that gangliosides GD3/GD2 enhance malignant phenotypes of cancers. Recently, we reported that human gliomas expressing GD3/GD2 exhibited enhanced malignant phenotypes. Here, we investigated the function of GD3/GD2 in glioma cells and GD3/GD2-expressing glioma-derived exosomes. As reported previously, transfectant cells of human glioma U251 MG expressing GD3/GD2 showed enhanced cancer phenotypes compared with GD3/GD2-negative controls. When GD3/GD2-negative cells were treated with exosomes secreted from GD3/GD2-positive cells, clearly increased malignant properties were observed. Furthermore, increased phosphorylation of signaling molecules was detected after 5-15 min of exosome treatment, ie, higher tyrosine phosphorylation of platelet-derived growth factor receptor, focal adhesion kinase, and paxillin was found in treated cells than in controls. Phosphorylation of extracellular signal-regulated kinase-1/2 was also enhanced. Consequently, it is suggested that exosomes secreted from GD3/GD2-positive gliomas play important roles in enhancement of the malignant properties of glioma cells, leading to total aggravation of heterogenous cancer tissues, and also in the regulation of tumor microenvironments., Competing Interests: The authors declare that they have no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF